Data is not available at this time.
Software Service, Inc. operates in the healthcare information services sector, specializing in electronic medical records (EMR) and hospital total ordering systems. The company serves medical institutions in Japan, leveraging its deep industry expertise since its founding in 1969. Its core revenue model is driven by software licensing, system integration, and maintenance services, ensuring recurring income streams. The firm’s solutions enhance operational efficiency for hospitals, positioning it as a trusted partner in Japan’s digitizing healthcare landscape. With no direct competitors disclosed, Software Service benefits from a niche focus on mission-critical healthcare IT infrastructure. Its long-standing presence and headquarters in Osaka reinforce regional credibility. The company’s emphasis on compliance and data security aligns with Japan’s stringent healthcare regulations, further solidifying its market position. While global EMR players exist, Software Service’s localized expertise and tailored solutions provide a competitive edge in its domestic market.
For FY 2024, Software Service reported revenue of ¥38.4 billion, with net income of ¥5.3 billion, reflecting a robust net margin of approximately 13.9%. Operating cash flow stood at ¥7.2 billion, significantly exceeding capital expenditures of ¥154 million, indicating strong cash generation efficiency. The company’s capital-light model is evident in its minimal reinvestment needs relative to profitability.
The firm’s diluted EPS of ¥1,018.92 underscores its earnings strength, supported by high-margin software services. With zero debt and ¥15.3 billion in cash reserves, Software Service exhibits exceptional capital efficiency. Its ability to convert earnings into free cash flow (operating cash flow less capex) highlights disciplined financial management and low operational leverage.
Software Service maintains a pristine balance sheet, with no debt and substantial cash holdings equivalent to nearly 24% of its market capitalization. This liquidity position provides flexibility for strategic initiatives or shareholder returns. The absence of leverage and consistent cash generation underscore the company’s low-risk financial profile.
While specific growth rates are undisclosed, the company’s focus on healthcare IT modernization aligns with sector tailwinds. A dividend of ¥130 per share suggests a payout ratio of approximately 12.8% based on EPS, indicating a conservative but sustainable distribution policy. Retained earnings likely support organic growth or future dividend increases.
At a market cap of ¥64.4 billion, the stock trades at roughly 12.1x net income, reflecting moderate valuation multiples. The low beta of 0.077 suggests minimal correlation to broader market volatility, possibly due to the defensive nature of healthcare IT demand. Investors may price in steady, rather than explosive, growth given the mature market.
Software Service’s entrenched position in Japan’s healthcare IT sector, coupled with its debt-free status and recurring revenue model, provides resilience. Regulatory tailwinds for EMR adoption and hospital digitization could drive incremental demand. However, growth may hinge on expanding service offerings or geographic reach beyond its current domestic focus.
Company description and financial data sourced from publicly available market data providers.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |